Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Vutiglabridin by Glaceum for Parkinson's Disease: Likelihood of Approval
Vutiglabridin is under clinical development by Glaceum and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase I...
Vutiglabridin by Glaceum for Age Related Macular Degeneration: Likelihood of Approval
Vutiglabridin is under clinical development by Glaceum and currently in Phase I for Age Related Macular Degeneration. According to GlobalData,...
Vutiglabridin by Glaceum for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
Vutiglabridin is under clinical development by Glaceum and currently in Phase I for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to GlobalData,...